Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 4012
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49193
Funny that the multi ID's talk about trial
(3)
Kelt
09/24/2018 9:14:20 AM
49192
Thanks. My youth came flashing back; the times
(1)
RusticBum
09/24/2018 8:54:31 AM
49191
Looking forward to see what October
bejamin
09/24/2018 8:48:14 AM
49190
Where did I say that IV drug works better? As
(1)
RusticBum
09/24/2018 8:47:52 AM
49189
Not a real big fan of this PR. If there is a
(2)
bejamin
09/24/2018 8:47:24 AM
49188
Excellent article showing why B-OM the leader of
(2)
petemantx
09/24/2018 8:37:30 AM
49187
What concern would a BP have with what IPIX is
(1)
petemantx
09/24/2018 8:29:11 AM
49186
Alan saw your post after I posted. Nice to see!
4kids
09/24/2018 8:11:45 AM
49185
News alert per Fidelity. Traveling so maybe
4kids
09/24/2018 8:04:19 AM
49184
Innovation Pharmaceuticals Provides a Comparative
(1)
AlanC
09/24/2018 7:43:26 AM
49183
If Leo doesn't have a deal done in October and
bejamin
09/24/2018 7:37:11 AM
49182
To finish, I think were buying time till 1st
(3)
Trading Pro Broker
09/24/2018 7:36:05 AM
49181
Good reminder to folks on the value of B-OM. A
Trading Pro Broker
09/24/2018 7:33:06 AM
49180
Very good discussion you started, like to see
bejamin
09/24/2018 7:31:39 AM
49179
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
09/24/2018 7:23:44 AM
49178
I know I'm not a fan of those who attempt to
(1)
BooDog
09/24/2018 7:23:39 AM
49177
and a PR on OM
smokenhot
09/24/2018 7:16:38 AM
49176
New B-OM comparison Blog
(2)
smokenhot
09/24/2018 7:02:28 AM
49175
IMO A big Pharma is doing due diligence and found
zdubble17
09/23/2018 11:08:54 PM
49174
I agree...but Im not concerned. If money were
Commando911
09/23/2018 10:25:10 PM
49173
No, it's not medical semantics. You're making a
(5)
Drano
09/23/2018 8:35:45 PM
49172
I think I love you!!! Kelt
Kelt
09/23/2018 8:33:16 PM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
49148
I have never heard of a long multi-identity in
(2)
petemantx
09/22/2018 1:10:28 PM
49147
Your right. That would be
Trading Pro Broker
09/22/2018 11:11:42 AM
49146
A reminder on how to use the Ignore feature:
Drano
09/22/2018 11:02:08 AM
49145
It's typical of many companies to have a large
(4)
Drano
09/22/2018 11:00:23 AM
49144
Multi identities on both sides create so much
(2)
bejamin
09/22/2018 10:59:06 AM
49143
I dont think it is a surprise. If it surprises
Trading Pro Broker
09/22/2018 10:48:51 AM
Newer
Older
Recent Articles
How $100 Invested in Moody's 15 Years Ago Has Grown
Understanding Shareholder Rights in Merger Investigations
Unlocking Value: A Deep Dive into JCDecaux's Liquidity Strategy
Understanding the Current Challenges Facing NIO Stock Prices
Real Estate Sector: Analyzing Unprecedented Buy Opportunities
Navigator Group Purchasing Partners with Foodbuy for Enhanced Services
NCAA President Charlie Baker to Discuss College Sports Evolution
NVIDIA's Sales Surge: The Greenlight for Growth Ahead
James Wynn's Risky Return to High-Leverage Bitcoin Trading
ProLogic ITS Partners with Signal 8 to Enhance Public Safety
Unity Software Experiences Stock Surge Following Analyst Upgrade
Kezar Life Sciences Advances in Autoimmune Hepatitis Trials
OSE Immunotherapeutics Reveals Recent Liquidity Contract Update
IPSEN's Recent Buy-Back Activities: Insights and Analysis
Exosens Expands Night Vision Capabilities Through NVLS Deal
Investment Growth: What $1000 in RB Global Could Yield
Zensai's Major Recognition as a Leading AI Innovator
Investigation Launched: Potential Class Action Against WAMCO
Guideline Faces Recommendations on 401(k) Claims from NAD
Chartwells Higher Education Achieves 25 NACUFS Awards in 2025
AGCO Takes Swift Action to Suspend Licenses of Fergus Bar
GIGABYTE Unveils New AI PC Models for Enthusiasts and Gamers
Analyzing the P/E Ratio for First United Inc. Stock Investors
The Drive Towards Fusion Energy: America's New Manhattan Project
Primak Construction Group: A Bold New Era for Growth
Whales Bet Big on Procter & Gamble: What You Should Know
Revolutionizing Edge AI: SiMa.ai Partners with Cisco
Analyzing Oscar Health's Stock Movements and Trends
Tetrate Introduces Agent Router for Enhanced GenAI Flexibility
Exploring the Recent Trends in American Airlines Options Trading
Investors Can Join Class Action Against Hims & Hers Health
United Airlines Earnings: Will Q2 Performance Elevate Stocks?
Behr Paint and Google Cloud Transform Color Choices with AI
Exciting Highlights of the 2025 ESL Rochester Fringe Festival
Empowering Food Security: Fidelis Care's Grant Opportunities
Federal Signal's Upcoming Earnings Call Brings Excitement
Investigation of Stock Transactions: TASK, VBTX, TURN Insights
Investigating Shareholder Rights: OLO and GNTY Sales Reviewed
BMO Launches Recovery Fund to Support Wildfire Impacted Communities
JMOON Launches Innovative Facial Toning Device in the USA
Explore Innovative Opportunities at EmTech MIT 2025
Charming Cottages Designed by Michael Kramer and Lilly Pulitzer
JPMorgan Chase's Strong Q2 Results Signal Future Growth
Exploring the Future of Crypto Mining with EarnMining App
Exploring the New Frontiers of Live Streaming with Pump.fun
Echelon Mark Unveils Innovative Web3 and DeFi Training Program
IPSEN's Strategic Share Buyback Program Insights for Investors
Cramer's Bold Proposal: Shift Apple from Buybacks to AI Innovation
Exosens Expands Night Vision Technology with Strategic NVLS Deal
Investors Under Scrutiny: Legal Probe on Biohaven's Practices